Cargando…

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma

OBJECTIVE: To evaluate the impact of preoperative chronic kidney disease (CKD) on oncological outcomes in patients with upper tract urothelial carcinoma who underwent radical nephroureterectomy. METHODS: A total of 426 patients who underwent radical nephroureterectomy at five medical centers between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kodama, Hirotake, Hatakeyama, Shingo, Fujita, Naoki, Iwamura, Hiromichi, Anan, Go, Fukushi, Ken, Narita, Takuma, Tanaka, Toshikazu, Kubota, Yuka, Horiguchi, Hirotaka, Momota, Masaki, Kido, Koichi, Matsumoto, Teppei, Soma, Osamu, Hamano, Itsuto, Yamamoto, Hayato, Tobisawa, Yuki, Yoneyama, Tohru, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Koie, Takuya, Ito, Hiroyuki, Yoshikawa, Kazuaki, Sasaki, Atsushi, Kawaguchi, Toshiaki, Sato, Makoto, Ohyama, Chikara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669959/ https://www.ncbi.nlm.nih.gov/pubmed/29137333 http://dx.doi.org/10.18632/oncotarget.20554

Ejemplares similares

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma
por: Horiguchi, Hirotaka, et al.
Publicado: (2018)

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma
por: Momota, Masaki, et al.
Publicado: (2018)

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy
por: Fukushi, Ken, et al.
Publicado: (2017)

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents
por: Hamano, Itsuto, et al.
Publicado: (2016)

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study)
por: Iwamura, Hiromichi, et al.
Publicado: (2021)

Clinical relevance of aortic calcification in urolithiasis patients
por: Tanaka, Toshikazu, et al.
Publicado: (2017)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer
por: Kusaka, Ayumu, et al.
Publicado: (2017)

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis
por: Tanaka, Yoshimi, et al.
Publicado: (2017)

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction
por: Narita, Takuma, et al.
Publicado: (2017)

Testicular Metastasis of Prostate Cancer: A Case Report
por: Kusaka, Ayumu, et al.
Publicado: (2014)

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer
por: Hamano, Itsuto, et al.
Publicado: (2017)

Frailty is a predictor of moderate to severe pain after robot‐assisted laparoscopic prostatectomy: A case‐control study (FRAP study)
por: Momota, Masaki, et al.
Publicado: (2020)

Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

A Case of Fibrous Pseudotumor in the Scrotum: Challenge for Diagnosis and Testicular Preservation
por: Kodama, Hirotake, et al.
Publicado: (2018)

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study
por: Anan, Go, et al.
Publicado: (2017)

Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study
por: Iwamura, Hiromichi, et al.
Publicado: (2015)

Renal cell carcinoma in a lumbar ectopic kidney
por: Hamano, Itsuto, et al.
Publicado: (2019)

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers
por: Soma, Osamu, et al.
Publicado: (2018)

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
por: Hamano, Itsuto, et al.
Publicado: (2020)

Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center
por: Hatakeyama, Shingo, et al.
Publicado: (2013)

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study
por: Fujita, Naoki, et al.
Publicado: (2023)

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
por: Koie, Takuya, et al.
Publicado: (2014)

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma
por: Hosogoe, Shogo, et al.
Publicado: (2017)

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
por: Fujita, Naoki, et al.
Publicado: (2023)

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study
por: Kubota, Yuka, et al.
Publicado: (2017)

Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level
por: Yoneyama, Tohru, et al.
Publicado: (2021)

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries
por: Konishi, Sakae, et al.
Publicado: (2021)

N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
por: Kodama, Hirotake, et al.
Publicado: (2021)

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan
por: Koie, Takuya, et al.
Publicado: (2015)

Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient
por: Narita, Takuya, et al.
Publicado: (2014)

A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy
por: Iwamura, Hiromichi, et al.
Publicado: (2014)

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery
por: Sato, Tendo, et al.
Publicado: (2016)

Narrative review of urinary glycan biomarkers in prostate cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2021)

Combination of Muscle Quantity and Quality Is Useful to Assess the Necessity of Surveillance after a 5-Year Cancer-Free Period in Patients Who Undergo Radical Cystectomy: A Multi-Institutional Retrospective Study
por: Fujita, Naoki, et al.
Publicado: (2023)

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer
por: Fujita, Naoki, et al.
Publicado: (2022)

Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study
por: Hagiwara, Kazuhisa, et al.
Publicado: (2016)

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation
por: Anan, Go, et al.
Publicado: (2019)

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis
por: Koie, Takuya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ikttc8hri30i3dpcjvr5sre1t7